Phase II Multicenter Study of the Antiepidermal Growth Factor Receptor Monoclonal Antibody Cetuximab in Combination With Platinum-Based Chemotherapy in Patients With Platinum-Refractory Metastatic and/or Recurrent Squamous Cell Carcinoma of the Head (Q56688854)
Jump to navigation
Jump to search
scientific article published on 11 July 2005
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase II Multicenter Study of the Antiepidermal Growth Factor Receptor Monoclonal Antibody Cetuximab in Combination With Platinum-Based Chemotherapy in Patients With Platinum-Refractory Metastatic and/or Recurrent Squamous Cell Carcinoma of the Head |
scientific article published on 11 July 2005 |
Statements
Phase II multicenter study of the antiepidermal growth factor receptor monoclonal antibody cetuximab in combination with platinum-based chemotherapy in patients with platinum-refractory metastatic and/or recurrent squamous cell carcinoma of the head and neck (English)
José Baselga
Jean Bourhis
Jacques Tortochaux
Hernán Cortés-Funes
Ricardo Hitt
Pere Gascón
Nadia Amellal
Andreas Harstrick
José M Trigo
11 July 2005